Evidence map›Paper›PMID 41912675›Full record

ArticleBritish journal of cancer2026

Who is benefiting from the dramatic decline in U.S. cancer mortality? Place-based evidence of disparities in rates of improvement.

Arthur G Cosby, Viswadeep Lebakula, Karissa Bergene, Gina Rico Mendez, Mackenzie Bumgarner, Alina Peluso

Abstract read
In one paragraph

Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arthur G CosbySocial Science Research Center, Mississippi State University, Starkville, MS, USA.
Viswadeep LebakulaGeospatial Science and Human Security Division, National Security Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, TN, USA. lebakulav@ornl.gov.ORCID http://orcid.org/0000-0001-5293-5914
Karissa BergeneSocial Science Research Center, Mississippi State University, Starkville, MS, USA.
Gina Rico MendezSocial Science Research Center, Mississippi State University, Starkville, MS, USA.ORCID http://orcid.org/0000-0002-8021-6981
Mackenzie BumgarnerOffice of Strategic Operations, William Carey University, Hattiesburg, MS, USA.
Alina PelusoComputational Sciences and Engineering Division, Computing and Computational Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, TN, USA.ORCID http://orcid.org/0000-0003-2895-0406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter decades of increasing cancer mortality, U.S. rates declined from 1991 to 2019, a 32% decrease. we investigated rates of cancer mortality improvement across 2954 counties and selected characteristics associated with mortality improvements.

methodsData was 21,381,009 county-level neoplasm deaths gleaned from death certificates via CDC WONDER. Analytical techniques included GIS and Moran's I, OLS, GWR models, and trend comparisons.

resultsCounties with the greatest improvement (reduction) in cancer mortality tended to be coastal, higher-income, metropolitan locations. OLS model (R DISCUSSION: Even though there was significant improvement in cancer mortality nationally, there were variations in the degree of improvement linked to county location, income, and urbanisation. These results underlie the need to expand place-based initiatives designed to advance cancer health and more equitable improvements in cancer mortality outcomes.

Indexed as

NeoplasmsHumansIncomeMortalitySocioeconomic Disparities in HealthUnited States

Identifiers

PMID41912675
PMCPMC13133269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.